Kisspeptin-10 – User Manual & Dosage Protocol Guide

Kisspeptin-10 is a synthetic decapeptide derived from the naturally occurring kisspeptin protein. It plays a central role in regulating the hypothalamic-pituitary-gonadal (HPG) axis by stimulating gonadotropin-releasing hormone (GnRH) secretion.

Kisspeptin signaling is critical for:

• Puberty onset
• Reproductive hormone regulation
• LH and FSH secretion
• Fertility research models

Disclaimer: Kisspeptin-10 is for research and experimental use only in this context. While kisspeptin analogs have been studied clinically, this product is not FDA-approved for general therapeutic use.

Lyophilized Powder

Freeze-dried Kisspeptin‑10 intended for reconstitution prior to use in research settings.

Reconstituted Solution

Prepared liquid form used as an injectable research preparation after proper dilution.

Note

Concentration may vary by supplier.

Kisspeptin-10 functions by:

• Binding to the KISS1R (GPR54) receptor
• Stimulating hypothalamic GnRH release
• Increasing pituitary secretion of LH and FSH
• Modulating testosterone or estrogen production downstream

It is commonly studied in reproductive endocrinology and fertility models.

Clinical Research (Human Studies)

Kisspeptin‑10 has been studied in controlled research and clinical environments. Dosing depends on indication and must be supervised by qualified professionals.

Subcutaneous (SC) Administration

• Typical Range: 100–500 µg
• Frequency: Single or intermittent dosing
• Notes: Commonly used in LH stimulation studies

Weight-Based Protocols

• Typical Range: 0.3–1.0 µg/kg
• Frequency: Single administration

Notes: Used in fertility and endocrine research models

Research Note

In most studies, Kisspeptin‑10 is given as a single injection to stimulate LH response, rather than as chronic daily dosing. Repeated administration protocols are generally spaced based on hormonal monitoring.

Baseline Assessment

Conducted pre-dose to measure LH, FSH, testosterone, or estradiol before administration.

Acute Administration

A single-dose phase used to evaluate LH response following Kisspeptin‑10 administration.

Monitoring Phase

Spanning 1–24 hours, this phase tracks hormonal responses post-administration.

Research Note

Long-term daily cycle protocols are less common than acute stimulation models in Kisspeptin‑10 studies.

Supplies

• Sterile bacteriostatic water
• Sterile syringe
• Alcohol swabs

Example Reconstitution

If using 5 mg vial:

Add 5 mL bacteriostatic water
→ Concentration = 1 mg/mL

Swirl gently to dissolve (do not shake).
Refrigerate at 2–8°C after reconstitution.
Use within 2–4 weeks or per protocol.

Subcutaneous Injection Model

• Common sites: abdomen
• Clean site prior to administration
• Inject slowly
• Rotate injection sites

Because Kisspeptin-10 strongly stimulates LH release, hormonal labs are often monitored post-administration.

Lyophilized Powder

Store in a cool, dry environment, with a shelf life up to the manufacturer’s expiration date.

Reconstituted Solution

Keep refrigerated at 2–8°C and use within 2–4 weeks after preparation.

Protection Guidelines

Protect from light and contamination to maintain quality.

Safety Note

Discard the solution if it becomes cloudy or discolored, as this may indicate degradation or contamination.

Kisspeptin-10 directly affects the HPG axis and may influence:

• LH/FSH levels
• Testosterone (males)
• Estradiol (females)
• Ovarian stimulation

Possible Side Effects

• Headache
• Flushing
• Nausea
• Temporary hormonal fluctuations

Suggested Monitoring

• LH
• FSH
• Total Testosterone (males)
• Estradiol (females)

Use should occur under professional supervision.

Peptide: Kisspeptin-10
Category: Reproductive Hormone / GnRH Modulator
Delivery: Subcutaneous injection
Typical Research Range: 100–500 mcg per administration
Use Pattern: Often single-dose stimulation models
Storage: Refrigerated after reconstitution